SQUAWK/NEWS
Menu
Live News EQUITY L impact

LakeShore Biopharma Files 6-K

LakeShore Biopharma submits periodic report to SEC

LSBP

Filed: 2026-05-28 AccNo: 0001213900-26-061817 Size: 25 KB